BioSpace News Archive

Citizens in New Brunswick and Manitoba are accessing their COVID-19 test results through a secure online portal enabled by technology from VeroSource Solutions.

Cullinan Oncology, LLC announced today the closing of a $98.5 million Series B financing, which will be used to support ongoing clinical trials across its small molecule and biologics portfolio. New institutional investors and family offices participated in the financing alongside o

Stilla Technologies, a leading French provider of pioneering solutions for high precision genetic analysis, is offering a new high-throughput and cost-effective testing approach for COVID-19 by combining its digital PCR technology with the group testing method and publishes the largest comparative study to date for group testing of SARS-CoV-2.

Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of healthcare economics studies INSPIRE and COMPARE

Aqualung Therapeutics has been awarded a three year NIH FAST-TRACK AWARD which will support mid- and late-stage development of a therapeutic to treat patients who undergo radiotherapy for treatment of lung & esophageal cancers and are at risk for developing Radiation-Induced Lung Injury.

Chemical Insights, an Institute of Underwriters Laboratories, is presenting a virtual program titled, “Emissions, Exposure and Health Impact on 3D Printing Processes” as part of American Industrial Hygiene Association’s (AIHA) upcoming American Industrial Hygiene Conference & Exposition.

Experion Holdings Ltd. is pleased to announce the launch of its premium brand, Citizen Stash, into Ontario where it will be available in stores and online in the coming weeks.

Vitro Diagnostics, Inc., dba Vitro entered into an exclusive Memorandum of Understanding with Global Institute of Stem Cell Therapy and Research, Inc. a leading stem cell research institute based in San Diego, California to jointly partner together for a COVID-19 Investigational New Drug to the FDA using Vitro Biopharma’s umbilical cord mesenchymal stem cell product AlloRx Stem Cells™ in a clinical trial to treat Covid-19 patients.

Hill Physicians Medical Group, California’s largest independent physician association, has announced its financial results for the 2019 calendar year.

Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in April 2020 and Applies to All Current IV DARZALEX® Indications in Frontline and Relapsed/Refractory Settings